Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I L Alimova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Voprosy Pitaniia|November 14, 2019
[Assessment of physical development and diet of primary school children in Smolensk]E A Tsukareva, A V Avchinnikov, I L Alimova
Klinicheskaia Laboratornaia Diagnostika|January 12, 2013
[The characteristics of lipid metabolism in children with congenital hypothyroidism against the background of substitutive therapy with L-thyroxin]T M Romankova, I L Alimova, V S Sukhorukov
Problemy Endokrinologii|November 12, 2021
[Clinical guidelines «Precocious puberty»]V A Peterkova, I L Alimova, E B Bashnina, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 8, 2015
[Open, non-comparative phase III clinical study to evaluate the efficacy and safety of sapropterin in patients with phenylketonuria and hyperphenylalaninemia]T V Bushueva, L M Kuzenkova, T É Borovik, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Voprosy Pitaniia|November 14, 2019
[Assessment of physical development and diet of primary school children in Smolensk]E A Tsukareva, A V Avchinnikov, I L Alimova
Klinicheskaia Laboratornaia Diagnostika|January 12, 2013
[The characteristics of lipid metabolism in children with congenital hypothyroidism against the background of substitutive therapy with L-thyroxin]T M Romankova, I L Alimova, V S Sukhorukov
Problemy Endokrinologii|November 12, 2021
[Clinical guidelines «Precocious puberty»]V A Peterkova, I L Alimova, E B Bashnina, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 8, 2015
[Open, non-comparative phase III clinical study to evaluate the efficacy and safety of sapropterin in patients with phenylketonuria and hyperphenylalaninemia]T V Bushueva, L M Kuzenkova, T É Borovik, et al.
Pageof 1